Dashboard
Manage Tickers

DCBODocebo Inc.

Nasdaq docebo.com


$ 38.06 $ -0.01 (-0.03 %)    

Monday, 10-Jun-2024 15:59:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 464.61 $ 1.87 (0.4 %)
DIA $ 389.34 $ 0.80 (0.21 %)
SPY $ 535.72 $ 1.65 (0.31 %)
TLT $ 90.89 $ -0.61 (-0.67 %)
GLD $ 213.56 $ 1.94 (0.92 %)
$ 38
$ 37.70
$ 0.00 x 0
$ 0.00 x 0
$ 37.70 - $ 38.09
$ 33.81 - $ 56.41
123,525
na
1.28B
$ 2.14
$ 197.96
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

craig-hallum-initiates-coverage-on-docebo-with-buy-rating-announces-price-target-of-58
Craig-Hallum Initiates Coverage On Docebo ...
06/07/2024 16:08:50

Craig-Hallum analyst George Sutton initiates coverage on Docebo (NASDAQ:DCBO) with a Buy rating and announces Price Target o...

reported-earlier-warburg-pincus-increases-investment-in-docebo-achieving-10-ownership
Reported Earlier, Warburg Pincus Increases...
05/31/2024 07:49:48

needham-reiterates-buy-on-docebo-maintains-45-price-target
Needham Reiterates Buy on Docebo, Maintain...
05/16/2024 10:06:19

Needham analyst Ryan MacDonald reiterates Docebo (NASDAQ:DCBO) with a Buy and maintains $45 price target.

canaccord-genuity-maintains-buy-on-docebo-lowers-price-target-to-55
Canaccord Genuity Maintains Buy on Docebo,...
05/14/2024 17:34:23

Canaccord Genuity analyst Robert Young maintains Docebo (NASDAQ:DCBO) with a Buy and lowers the price target from $65 to $55.

scotiabank-maintains-sector-outperform-on-docebo-lowers-price-target-to-50
Scotiabank Maintains Sector Outperform on ...
05/14/2024 16:40:34

Scotiabank analyst Kevin Krishnaratne maintains Docebo (NASDAQ:DCBO) with a Sector Outperform and lowers the price target fr...

cibc-maintains-outperformer-on-docebo-lowers-price-target-to-53
CIBC Maintains Outperformer on Docebo, Low...
05/13/2024 16:47:38

CIBC analyst Stephanie Price maintains Docebo (NASDAQ:DCBO) with a Outperformer and lowers the price target from $58 to $53.

morgan-stanley-maintains-overweight-on-docebo-lowers-price-target-to-59
Morgan Stanley Maintains Overweight on Doc...
05/13/2024 16:35:27

Morgan Stanley analyst Josh Baer maintains Docebo (NASDAQ:DCBO) with a Overweight and lowers the price target from $65 to $59.

goldman-sachs-maintains-neutral-on-docebo-lowers-price-target-to-48
Goldman Sachs Maintains Neutral on Docebo,...
05/13/2024 15:47:21

Goldman Sachs analyst Kevin Kumar maintains Docebo (NASDAQ:DCBO) with a Neutral and lowers the price target from $55 to $48.

crocs-to-rally-around-19-here-are-10-top-analyst-forecasts-for-monday
Crocs To Rally Around 19%? Here Are 10 Top...
05/13/2024 12:31:26

needham-maintains-buy-on-docebo-lowers-price-target-to-45
Needham Maintains Buy on Docebo, Lowers Pr...
05/13/2024 09:30:26

Needham analyst Ryan MacDonald maintains Docebo (NASDAQ:DCBO) with a Buy and lowers the price target from $63 to $45.

why-diodes-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Diodes Shares Are Trading Lower By Aro...
05/10/2024 16:44:44

morgan-stanley-maintains-overweight-on-docebo-lowers-price-target-to-65
Morgan Stanley Maintains Overweight on Doc...
04/19/2024 17:17:52

Morgan Stanley analyst Josh Baer maintains Docebo (NASDAQ:DCBO) with a Overweight and lowers the price target from $67 to $65.

goldman-sachs-maintains-neutral-on-docebo-raises-price-target-to-55
Goldman Sachs Maintains Neutral on Docebo,...
02/26/2024 17:40:58

Goldman Sachs analyst Kevin Kumar maintains Docebo (NASDAQ:DCBO) with a Neutral and raises the price target from $44 to $55.

Core News & Articles
Scotiabank Maintains Sector Outperform on ...
02/26/2024 17:01:17

Scotiabank analyst Kevin Krishnaratne maintains Docebo (NASDAQ:DCBO) with a Sector Outperform and raises the price target fr...

morgan-stanley-maintains-overweight-on-docebo-raises-price-target-to-67
Morgan Stanley Maintains Overweight on Doc...
02/26/2024 15:49:16

Morgan Stanley analyst Josh Baer maintains Docebo (NASDAQ:DCBO) with a Overweight and raises the price target from $63 to $67.

why-mercadolibre-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why MercadoLibre Shares Are Trading Lower ...
02/23/2024 19:07:11

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter fin...

carvana-posts-q4-results-joins-legalzoomcom-comfort-systems-and-other-big-stocks-moving-higher-on-friday
Carvana Posts Q4 Results, Joins LegalZoom....
02/23/2024 16:58:59

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.

docebo-expects-q1-revenue-of-510m-513m-vs-5091m-est
Docebo Expects Q1 Revenue of $51.0M-$51.3M...
02/23/2024 11:35:51

Financial Outlook Docebo is providing financial guidance for the three months ended March 31, 2024 as follows: Total revenu...

docebo-q4-adj-eps-026-beats-008-estimate-sales-4928m-beat-4840m-estimate
Docebo Q4 Adj EPS $0.26 Beats $0.08 Estima...
02/23/2024 11:33:36

Docebo (NASDAQ:DCBO) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.08 by 225 p...

earnings-scheduled-for-february-23-2024
Earnings Scheduled For February 23, 2024
02/23/2024 09:44:11

Companies Reporting Before The Bell • Fomento Economico (NYSE:FMX) is likely to report quarterly earnings at $1.61 per share o...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)